Anne Lesage
Founder presso PHARVARIS N.V.
Patrimonio netto: 6 M $ in data 31/03/2024
Profilo
Anne Lesage is the founder of GrayMatters Consulting BVBA (founded in 2010), Kosa Pharma GmbH (founded in 2013), Pharvaris NV (founded in 2015), and Pharvaris GmbH (founded in 2015).
She holds the title of Chief Early Development Officer at Pharvaris NV and Pharvaris GmbH.
Dr. Lesage earns a doctorate degree from Ghent University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
PHARVARIS N.V.
0.61% | 10/03/2023 | 250 000 ( 0.61% ) | 6 M $ | 31/03/2024 |
Posizioni attive di Anne Lesage
| Società | Posizione | Inizio |
|---|---|---|
| PHARVARIS N.V. | Founder | 30/09/2015 |
Pharvaris GmbH
 Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Pharvaris GmbH operates as a clinical-stage company. It specializes in medicinal chemistry, drug discovery and development and hereditary angioedema. The company was founded by Berndt A. E. Modig, Jochen Knolle, Anne Lesage and Hans G. C. P. Schikan in October 2015 and is headquartered in Zug, Switzerland. | Founder | 01/10/2015 |
Precedenti posizioni note di Anne Lesage
| Società | Posizione | Fine |
|---|---|---|
| Kosa Pharma GmbH | Founder | - |
| GrayMatters Consulting BV | Founder | - |
Formazione di Anne Lesage
| Ghent University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PHARVARIS N.V. | Health Technology |
| Aziende private | 3 |
|---|---|
| GrayMatters Consulting BV | |
Pharvaris GmbH
Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Pharvaris GmbH operates as a clinical-stage company. It specializes in medicinal chemistry, drug discovery and development and hereditary angioedema. The company was founded by Berndt A. E. Modig, Jochen Knolle, Anne Lesage and Hans G. C. P. Schikan in October 2015 and is headquartered in Zug, Switzerland. | Health Technology |
| Kosa Pharma GmbH |
- Borsa valori
- Insiders
- Anne Lesage
